Shih IeM - Search Results

1

Clinical and biological significance of HLA-G expression in ovarian cancer.

Sheu JJ, Shih IeM. Sheu JJ, et al. Among authors: shih iem. Semin Cancer Biol. 2007 Dec;17(6):436-43. doi: 10.1016/j.semcancer.2007.06.012. Epub 2007 Jul 3. Semin Cancer Biol. 2007. PMID: 17681474 Free PMC article. Review.

2

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.

Singer G, Kurman RJ, McMaster MT, Shih IeM. Singer G, et al. Among authors: shih iem. Am J Surg Pathol. 2002 Jul;26(7):914-20. doi: 10.1097/00000478-200207000-00010. Am J Surg Pathol. 2002. PMID: 12131159

3

Identifying tumor origin using a gene expression-based classification map.

Buckhaults P, Zhang Z, Chen YC, Wang TL, St Croix B, Saha S, Bardelli A, Morin PJ, Polyak K, Hruban RH, Velculescu VE, Shih IeM. Buckhaults P, et al. Among authors: shih iem. Cancer Res. 2003 Jul 15;63(14):4144-9. Cancer Res. 2003. PMID: 12874019

4

HLA-G is a potential tumor marker in malignant ascites.

Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann E, Grosse-Wilde H, Cheng CC, Kurman RJ, Shih IeM. Singer G, et al. Among authors: shih iem. Clin Cancer Res. 2003 Oct 1;9(12):4460-4. Clin Cancer Res. 2003. PMID: 14555519

5

Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.

Ho CL, Kurman RJ, Dehari R, Wang TL, Shih IeM. Ho CL, et al. Among authors: shih iem. Cancer Res. 2004 Oct 1;64(19):6915-8. doi: 10.1158/0008-5472.CAN-04-2067. Cancer Res. 2004. PMID: 15466181

6

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.

Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM. Davidson B, et al. Among authors: shih iem. Gynecol Oncol. 2005 Jan;96(1):42-7. doi: 10.1016/j.ygyno.2004.09.049. Gynecol Oncol. 2005. PMID: 15589578

7

Apolipoprotein E is required for cell proliferation and survival in ovarian cancer.

Chen YC, Pohl G, Wang TL, Morin PJ, Risberg B, Kristensen GB, Yu A, Davidson B, Shih IeM. Chen YC, et al. Among authors: shih iem. Cancer Res. 2005 Jan 1;65(1):331-7. Cancer Res. 2005. PMID: 15665311

8

HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract.

Hansel DE, Rahman A, Wilentz RE, Shih IeM, McMaster MT, Yeo CJ, Maitra A. Hansel DE, et al. Among authors: shih iem. Int J Gastrointest Cancer. 2005;35(1):15-23. doi: 10.1385/ijgc:35:1:015. Int J Gastrointest Cancer. 2005. PMID: 15722570

9

Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations.

Pohl G, Ho CL, Kurman RJ, Bristow R, Wang TL, Shih IeM. Pohl G, et al. Among authors: shih iem. Cancer Res. 2005 Mar 1;65(5):1994-2000. doi: 10.1158/0008-5472.CAN-04-3625. Cancer Res. 2005. PMID: 15753399

10

Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma.

Chen YC, Davidson B, Cheng CC, Maitra A, Giuntoli RL 2nd, Hruban RH, Wang TL, Shih IeM. Chen YC, et al. Among authors: shih iem. Biochim Biophys Acta. 2005 Aug 15;1730(2):96-102. doi: 10.1016/j.bbaexp.2005.06.008. Biochim Biophys Acta. 2005. PMID: 16084606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters